Information about the impact of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in patients with liver cancer is lacking. This study characterizes the outcomes and mortality risk in this population.

Outcome of liver cancer patients with SARS-CoV-2 infection: An International, Multicentre, Cohort Study

Rimassa, Lorenza;
2022

Abstract

Information about the impact of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in patients with liver cancer is lacking. This study characterizes the outcomes and mortality risk in this population.
COVID-19
hepatocellular carcinoma
liver cancer
mortality
COVID-19 Testing
Cohort Studies
Cross-Sectional Studies
Humans
Retrospective Studies
SARS-CoV-2
COVID-19
Carcinoma, Hepatocellular
Liver Neoplasms
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: http://hdl.handle.net/11699/68344
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 0
  • ???jsp.display-item.citation.isi??? 0
social impact